UBS Lux Equity Fund Biotech USD vs Evli High Yield

UBS Lux Equity Fund Biotech USD vs Evli High Yield

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. Evli High Yield

  • Security

    Evli High Yield B

  • Fee

    1.11%

  • ISIN

    FI0008803929

  • Holdings

    18

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.35) and Moderna (9.21). In comparison with Evli High Yield, we have 18 holdings where Iliad Holding is the largest holding (1.39), followed by Lorca Telecom Bondco (1.38) and BPCE (1.27).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Evli High Yield.

UBS Lux Equity Fund Biotech USD Evli High Yield
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Iliad Holding SAS
France
1.39 %
2. Vertex Pharmaceuticals Inc
9.35 %
2. Lorca Telecom Bondco SAU
Spain
1.38 %
3. Moderna Inc
9.21 %
3. BPCE SA
France
1.27 %
4. Alnylam Pharmaceuticals Inc
6.96 %
4. Allianz SE
Germany
1.16 %
5. AbbVie Inc
USA
5.53 %
5. Zegona Finance Plc
UK
1.08 %
6. Gilead Sciences Inc
USA
4.66 %
6. Telefónica Europe BV
Netherlands
1.07 %
7. Amgen Inc
4.3 %
7. Dynamo Newco II GmbH
Germany
1.05 %
8. BioNTech SE
4.13 %
8. Nidda Healthcare Holding GmbH
Germany
1.05 %
9. Karuna Therapeutics Inc
3.75 %
9. Ardonagh Finco Ltd
UK
1.04 %
10. Royalty Pharma Plc
3.37 %
10. Ziggo Bond Company BV
Netherlands
1.03 %
- 11. UPCB Finance VII Ltd
Cayman Islands
1.02 %
- 12. Fabbrica Italiana Sintetici SpA
Italy
1 %
- 13. Progroup AG
Switzerland
0.99 %
- 14. NTI Group Holding ApS
Denmark
0.98 %
- 15. Boels Topholding NV
Netherlands
0.98 %
- 16. Eroski Sociedad Cooperativa
Spain
0.97 %
- 17. Intrum AB
0.92 %
- 18. IQVIA Inc
0.92 %

The list of fund holdings was last updated on June 5, 2025.